2015
$60M
from 11 investors over 11 rounds
AVROBIO raised $60M on February 1, 2018
Investors: Leerink Partners LLC, Research Division, Aisling Capital, Atlas Venture, SV Life Sciences, Clarus Ventures, LLC, Brace Pharma Capital and Morningside Venture Partners
AVROBIO raised $25M on August 2, 2016
Investors: Atlas Venture, SV Life Sciences and Clarus Ventures, LLC
AVROBIO raised undisclosed on February 18, 2016
Investors: Atlas Venture